What's Too Far?

The marriage of technology and genomics is enabling researchers and consumers to learn more and more about their genetic background and risk of disease and empower people to take better control of their health. But, Karthika Muthukumaraswamy wonders at the Huffington Post whether this will be taken too far.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.